Clinical trial Recruiting at 1 site Interventional Ages 55 to 75

Investigating the impact of hearing aids on cognitive decline in older adults

Official title: Early Age-Related Hearing Loss Investigation (EARHLI): A Randomized Controlled Trial to Assess the Mechanisms Linking Early Age-Related Hearing Loss and Alzheimer's Disease and Related Dementias

Run by Columbia University · NCT06174038 · Data updated 2026-11-12

This study is testing if using hearing aids can help older adults with early hearing loss and mild memory problems think better and stay socially active compared to those who only get health education.

More Cognitive Impairment trials

Quick facts

Study typeInterventional
Ages55 Years to 75 Years
SexAll
Enrollment150 (estimated)
SponsorColumbia University
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedAugust 1, 2024
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedAugust 12, 2026
Trial IDNCT06174038 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 55-75 with mild to moderate age-related hearing loss and amnestic mild cognitive impairment.

Probably not a fit

Patients with congenital hearing loss or those whose hearing loss began before middle age may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Early Age-Related Hearing Loss Investigation (EARHLI) is a randomized controlled trial that aims to assess the effects of a hearing intervention, including hearing aids, compared to a health education program in late middle-aged adults with early-stage age-related hearing loss and mild cognitive impairment. Participants aged 55-75 will be enrolled and followed for one year, with assessments of cognition, social engagement, and brain connectivity conducted at the start, 6 months, and 12 months. The study will involve approximately 150 participants, with half receiving hearing aids at the beginning and the other half at the end of the trial.

Why it matters

Potential benefit: If successful, this study could lead to improved cognitive function and quality of life for older adults at risk for Alzheimer's Disease.

How similar studies have gone: Other studies have shown promising results in the relationship between hearing interventions and cognitive outcomes, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 55-75 years of age
* Adult-onset hearing loss of approximately mild to moderate in severity (4-frequency 0.5, 1, 2, 4 kHz pure tone average 20 dB to 55 dB HL in better hearing ear)
* Aidable hearing loss, defined by word recognition score in quiet ≥ 60% in better hearing ear
* Amnestic mild cognitive impairment (MCI) defined by Mini-Mental State Exam (MMSE2) score \>23, Clinical Dementia Rating (CDR) global score equivalent = 0.5, and ADNI3 criteria of Logical Memory II score of ≤6 if 0-7 years of education, ≤9 if 8-15 years, and ≤11 if ≥16 years
* Availability of a study partner (informant) for the administration of the cognitive screen and the ADCS-Activities of Daily Living-Prevention Instrument (ADCS-ADL-PI)
* Community-dwelling
* Fluent in English or Spanish
* Availability of participant in area for study duration

Exclusion Criteria:

* Self-reported congenital hearing loss, known genetic mutation-related hearing loss, or hearing loss onset before middle age (\<45 years old)
* Prior dementia diagnosis
* Reported disability in ≥ 2 activities of daily living (ADLs)
* Current or previous consistent hearing aid user (such as utilization of hearing aids within the past 6 months beyond brief trials)
* Unwillingness to wear hearing aids regularly (≥8 hours/day)
* Medical contraindications to the use of hearing aids (e.g., actively draining ear)
* Corrected vision impairment (worse than 20/63 on MNRead Acuity Chart in worse eye)
* Untreatable conductive hearing loss with air-bone gap \> 15 dB in two or more contiguous octave frequencies in both ears

Where it's running

  • Columbia University Medical Center
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.